Molecular and pharmacodynamic interactions between caffeine and dopaminergic system

Many drugs targeting dopaminergic system were developed for treating schizophrenia (antagonists of D2 dopaminergic receptors, e.g. antipsychotics) or Parkinson’ disease (agonists of dopaminergic receptors, e.g. L-DOPA). Because many of the patients treated with these drugs consume caffeine based bev...

Descripción completa

Detalles Bibliográficos
Autores principales: Voiculescu, M, Ghiță, I, Segărceanu, A, Fulga, I, Coman, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2014
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813614/
https://www.ncbi.nlm.nih.gov/pubmed/27057246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813614/
https://www.ncbi.nlm.nih.gov/pubmed/27057246

Ejemplares similares